Federica Mazzuca

Pubblicazioni

Titolo Pubblicato in Anno
The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon? FRONTIERS IN IMMUNOLOGY 2021
How technology can help in oncologic patient management during COVID-19 outbreak EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 2020
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 2020
The 5-Ws of immunotherapy in head and neck cancer CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2020
[18F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020
Combination therapy of high-dose rabeprazole plus metronomic capecitabine in advanced gastrointestinal cancer: a randomized phase II trial CANCERS 2020
Evaluation of prognostic factors for survival in transverse colon cancer CANCERS 2020
Risk of coronavirus disease 2019 in patients treated for cancer. An immune response–based hypothesis EUROPEAN JOURNAL OF CANCER 2020
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer. The multicenter “SLAVE” study CANCERS 2020
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer. The multicenter “SLAVE” study CANCERS 2020
[18F]FDG-PET/CT and long-term response to everolimus in advanced neuroendocrine neoplasia ANNALS OF ONCOLOGYANNALS OF ONCOLOGY 2020
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC). ANNALS OF ONCOLOGY 2020
Impact of tumor site on the prognosis of small bowel adenocarcinoma TUMORI 2019
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab JOURNAL OF TRANSLATIONAL MEDICINE 2019
Clinical impact of highly purified, whey proteins in patients affected with colorectal cancer undergoing chemotherapy: preliminary results of a placebo-controlled study INTEGRATIVE CANCER THERAPIES 2019
Drug resistance of BRAF-mutant melanoma: Review of up-to-date mechanisms of action and promising targeted agents EUROPEAN JOURNAL OF PHARMACOLOGY 2019
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient CASE REPORTS IN ONCOLOGICAL MEDICINE 2019
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab. a real-life multicentre study JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Multidisciplinary management of neuroendocrine neoplasia: a real-world experience from a referral center JOURNAL OF CLINICAL MEDICINE 2019
A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy ANNALS OF ONCOLOGY 2019

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma